All Type of News
KFDA to strengthen drug monitoring system
The Korea Food and Drug Administration held its information session over drug surveillance business guideline in a bid to help understand local drugmakers drug related safety guidelines in a detailed manner.
The se...
GCJBP to submit clinical data of Laennec placenta injection
GCJBP, a local importer of Laennec placenta injection from Japan Bio Products (JBP), says it is scheduled to submit clinical data of Laennec placenta injection to the Korea Food and Drug Administration at the end of t...
Myungmoon steps up support for biopharmaceutical business
Myungmoon Pharm has a new objective to advance into biopharmaceutical business sector while securing new engines for future growth.
The biopharmaceutical market was estimated to be worth over $79 billion in 2007 wi...
Creagene-Choongwae merger expected during May 1
Creagene Holdings’ merger with Choong-wae Pharm is due on May 1, it was announced at the special shareholders meeting of Creagene on March 27.
With appointment of three directors, Creagene-Choongwae merger is expec...
Kolon Life Science to go public
Kolon Life Science, Inc. (KLS), a subsidiary company of Kolon Group, is in the process of stepping into the secondary stock market Kosdaq.
The company is scheduled to sell 720,000 shares in its public offerings to ...
Green Cross to seek re-approval over human placenta injection
Green Cross Corporation said on March 26 that it will proceed to re-apply for its Greenpla, which was judged by the Korea Food and Drug Administration to be ineffective for treatment of climacteric disturbance.
Acc...
Hanmi likely to post double-digit growth
Market observers projected on March 26 that Hanmi Pharm's progress this year will fall into the double-digit territory.
“The market consensus is that boosted by robust sales of new products, including esomeprazole ...
Concerns mounting over RMS Korea
Korean Pharmaceutical firms and wholesalers need to assess the possible damage that foreign investment funds’ improper acquisition over local wholesaling firms would cause in the future and map out proper countermeasu...
Civil group calls for wider access to OTC products
A civic group has urged the Korean Pharmaceutical Association that supermarkets sell OTC products whose safety profiles are already established.
The Citizens’ Coalition for Economic Justice said on its statement th...
Leading OTC drugmakers rushing to price hike game
Domestic OTC manufacturers are considering joining the price increase rally of their popular OTC products to cushion the impact on soaring raw material costs due to the Korean currency’s steep depreciation.
The pri...
